Global Central Laboratories, Clinical Development Services Moving To
Marietta
RESEARCH TRIANGLE PARK, N.C., July 5 /PRNewswire/ -- Quintiles
Transnational Corp. today announced plans to expand and consolidate its
Global Central Laboratories in Smyrna, Ga., and its Clinical Development
Services (CDS) office in Atlanta within a single structure in nearby
Marietta, Ga.
The 201,366-square-foot, three-story structure in Marietta will more
than double the combined space now occupied by Global Central Laboratories
in Smyrna and CDS in Atlanta, allowing for the addition of about 400 jobs
through 2011. Renovation of the structure is expected to begin the third
quarter of 2007, with the first groups of employees scheduled to move
during the second quarter of 2008.
"For our Global Central Laboratories, this is another expansion to
accommodate the growth of our business, following the additions of labs in
China and India and expansion of our lab in Scotland," said Dennis
Gillings, CBE, Chairman and CEO of Quintiles Transnational. "The increasing
demand for our CDS and laboratory services is driving the need to expand,
and we're taking this opportunity to bring our Atlanta units together to
improve coordination and efficiency for our customers."
Tom Wollman, Senior Vice President, Global Central Laboratories, said
Quintiles wished to acknowledge the support of Cobb County, the Georgia
Cancer Coalition, the Georgia Research Alliance and the Georgia Department
of Economic Development for their support of this project. "With their
help, Quintiles will be able to add up to 400 jobs in a rapidly expanding
field. By more than doubling our capacity in the Atlanta area, we can stay
ahead of the escalating demand for our services."
The value of the incentive package is estimated at $11 million and
includes training, collaborations with the Georgia Research Alliance
Technology Fund and access to the Georgia Cancer Coalition and its
Distinguished Cancer Clinician and Scientist Program. The Cancer Coalition
has a network of more than 100 oncologists ready to work with Quintiles on
new clinical trials.
The project is being managed by Solution Property Group and renovation
is being done by Purdum Construction of Kansas City, Mo. Quintiles is
investing $19 million in the project.
About Quintiles Global Central Laboratories
Quintiles Laboratories owns a network of clinically harmonized
facilities in the U.S., Europe, South Africa, China, India and Singapore,
and has tightly controlled sub-contractor laboratories in Argentina and
Brazil managed by Quintiles employees located in each of the facilities.
About Quintiles
Quintiles Transnational Corp. is powering the next generation of
healthcare by providing a broad range of professional services in drug
development, financial partnering and commercialization for the
pharmaceutical, biotechnology and healthcare industries. With about 18,000
employees and offices in more than 50 countries, it is focused on providing
customer-centric solutions that are the gold standard of the industry. For
more information, please visit the company's Web site at http://www.quintiles.com.
SOURCE Quintiles Transnational Corp.
 back to top
Related links:
http://www.quintiles.com
CONTACT:
Dick Jones, Media Relations, +1-919-998-2091,
or media.info@quintiles.com, or Greg Connors, Investor Relations,
+1-919-998-2000, or invest@quintiles.com, both of Quintiles
Transnational Corp.
|
